New Insights into the Link between Melanoma and Thyroid Cancer: Role of Nucleocytoplasmic Trafficking
Open Access
- 10 February 2021
- Vol. 10 (2), 367
- https://doi.org/10.3390/cells10020367
Abstract
Cancer remains a major public health concern, mainly because of the incompletely understood dynamics of molecular mechanisms for progression and resistance to treatments. The link between melanoma and thyroid cancer (TC) has been noted in numerous patients. Nucleocytoplasmic transport of oncogenes and tumor suppressor proteins is a common mechanism in melanoma and TC that promotes tumorigenesis and tumor aggressiveness. However, this mechanism remains poorly understood. Papillary TC (PTC) patients have a 1.8-fold higher risk for developing cutaneous malignant melanoma than healthy patients. Our group and others showed that patients with melanoma have a 2.15 to 2.3-fold increased risk of being diagnosed with PTC. The BRAF V600E mutation has been reported as a biological marker for aggressiveness and a potential genetic link between malignant melanoma and TC. The main mechanistic factor in the connection between these two cancer types is the alteration of the RAS-RAF-MEK-ERK signaling pathway activation and translocation. The mechanisms of nucleocytoplasmic trafficking associated with RAS, RAF, and Wnt signaling pathways in melanoma and TC are reviewed. In addition, we discuss the roles of tumor suppressor proteins such as p53, p27, forkhead O transcription factors (FOXO), and NF-KB within the nuclear and cytoplasmic cellular compartments and their association with tumor aggressiveness. A meticulous English-language literature analysis was performed using the PubMed Central database. Search parameters included articles published up to 2021 with keyword search terms melanoma and thyroid cancer, BRAF mutation, and nucleocytoplasmic transport in cancer.Funding Information
- Carol Lavin Bernick Faculty Grant (631465)
This publication has 122 references indexed in Scilit:
- Importazole, a Small Molecule Inhibitor of the Transport Receptor Importin-βACS Chemical Biology, 2011
- Small molecule peptidomimetic inhibitors of importin α/β mediated nuclear transportBioorganic & Medicinal Chemistry, 2010
- Identification of a Small Molecule Inhibitor of Importin β Mediated Nuclear Import by Confocal On-Bead Screening of Tagged One-Bead One-Compound LibrariesACS Chemical Biology, 2010
- STRA8 Shuttles between Nucleus and Cytoplasm and Displays Transcriptional ActivityOnline Journal of Public Health Informatics, 2009
- Molecular markers of aggressiveness of thyroid cancerCurrent Opinion in Endocrinology, Diabetes and Obesity, 2009
- Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 InhibitionCancer Research, 2009
- Activated Wnt/ß-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma modelProceedings of the National Academy of Sciences of the United States of America, 2009
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Structure-based design of a pathway-specific nuclear import inhibitorNature Structural & Molecular Biology, 2007
- Mutations of the BRAF gene in human cancerNature, 2002